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In order to study the antipyretic effect of inhibitors of protein synthesis, hypothalamic tissue
was incubated in vitro under controlled conditions and the amount of prostaglandin E2 (PGE2)
measured in the supernatant medium. Rabbit anterior hypothalamic tissue was incubated with
purified human leukocytic pyrogen (LP) and after 60 minutes the supernatant fluid was assayed
for PGE2 by radioimmunoassay. Control tissue incubated with Eagle's medium (MEM) released
elevated levels ofPGE2; however, the additon ofpolymyxin B (PmxB), acationic antibiotic which
blocks the activities of bacterial endotoxins, significantly reduced PGE2. In addition, endotoxin
added to MEM induced from the brain tissue PGE2 production which could be reduced by the
addition of PmxB. Thus, commercial culture media such as MEM may contain sufficient
amounts ofendotoxin to stimulate brain PGE2 production in vitro. Purified human LP incubated
with hypothalamic tissue in the presence ofPmxB induced PGE2 production in a dose-dependent
fashion. This release could be reduced (p < 0.001) by the presence of either cycloheximide or
puromycin during incubation with LP. The addition of these inhibitors to unstimulated
hypothalamic tissue incubations did not reduce background levels of PGE2. It is concluded that
the antipyretic effect of protein synthesis inhibitors results in a specific decrease in LP-induced
levels ofPGE2-
INTRODUCTION
Substantial evidence exists that leukocytic pyrogen (LP) produces fever by first
stimulating the production of prostaglandin E (PGE) in the anterior hypothalamus
[1,2,3]. Oncereleased, PGEand possibly othercyclo-oxygenase products bring about a
riseinthetemperatureset-point ofthe hypothalamus with thesubsequent development
of a fever by physiologic (e.g, shivering and vasoconstriction) and behavioral means
[4]. Recently we have shown that purified LP induces the synthesis of PGE2 from
rabbit brain tissue in vitro [5]. This response is dose-related and can be eliminated by
inactivation of LP with moderate heating. An advantage of this in vitro assay is that
the effects of LP-induced PGE2 synthesis as well as other neurochemical changes can
be directly studied under controlled conditions.
In addition to inhibitors of cyclo-oxygenase such as aspirin and indomethacin,
inhibitors ofprotein synthesis such as cycloheximide (Cyhx) and anisomycin have been
shown to act as antipyretic agents [6]. Injection ofCyhx into rabbits prevents feverdue
to intravenous injection ofendotoxin or LP [7,8,9]. The mechanism ofthis antipyresis,
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however, is uncertain. With this fact in mind, the current study was undertaken to
examine the effects of protein synthesis inhibitors (e.g., puromycin and Cyhx) on the
LP-induced production of PGE2 from rabbit hypothalami. The results indicate that
Cyhx and puromycin decrease LP-induced hypothalamic PGE2 release. This response
may be due to the ability of protein synthesis inhibitors to decrease the synthesis of
enzyme(s) needed for prostaglandin synthesis.
METHODS AND MATERIALS
Purification ofHuman LP
Human LP was produced from plateletpheresis by-products rich in monocytes. The
mononuclear cells were separated, suspended, and stimulated with heat-killed Staphy-
lococcus albus as previously described [10]. The crude 24-hour supernatant was first
fractionated using a Millipore Pellicon concentratingdevice (Millipore, Bedford, MA)
which excluded molecules greater than 100 kD and concentrated molecules between
100 and 10 kD. This concentrate was then dialyzed against pH 7.4 phosphate-buffered
saline and passed over an anti-human LPaffinity column; the LP was eluted with citric
acid as previously reported [11]. This material was then concentrated in 10 percent
lysine HCI and chromatographed over Sephadex G-50 (fine), 170 x 5.0 cm in 0.15 M
NaCl at 40C. The 15 kD peak ofpyrogen activity was isolated and concentrated in 3.5
kD cut-offdialysis bags submerged in polyethylene glycol, 8-10 kD. An aliquot ofthis
material, when precipitated with trichloracetic acid and applied to 17 percent
polyacrylamide gels in SDS, revealed a single band stained with Coomassie blue. LP
intended for biological assay was not run on gels but assayed in New Zealand albino
rabbits by intravenous injection. Rectal temperatures were recorded every minute
using indwelling Yellow Spring thermistors (Yellow Spring Instruments, Yellow
Spring, OH) on a Digistrip II constant recording device (Kaye Instruments, Bedford,
MA). Each lot ofpurified LP was assayed in 2 kg rabbits, and peak fevers between 0.6
and 0.90C were considered a rabbit pyrogen dose (RPD). Using this method, peak
fever in 100 rabbits occurred at 46.9 ± 8.9 minutes (SD). Each lot ofLP was aliquoted
and kept frozen at -220C until used.
Production ofPGE2 by Rabbit Brain Tissue
For each experiment, a rabbit was sacrificed by rapid CO2 asphyxiation. Within one
minute, the spinal cord was severed and the brain was removed from the rostral to
frontal end, severing the pituitary stalk. The anterior hypothalamus was excised and
quickly placed in ice-cold Eagle's minimal essential medium (MEM, Microbiological
Associates, Walkerville, MD, containing 0.01 M HEPES buffer, 100 units penicillin
G/ml, and 100,ug streptomycin/ml) as previously described [5]. Theoptic chiasm was
dissected away and discarded. The hypothalamic tissue was then weighed, minced into
0.5 mm3 sections, and suspended in MEM at a concentration of 10 mg/ml. 1.0 ml
aliquotsofthesuspension werethen added to 12 x 75 mm polypropylene tubes (Falcon
Plastics, Oxnard, CA). The aliquots were incubated for 30 minutes in a 370C shaking
water bath. After this time, 3 ml of warm MEM were added to each tube and the
suspensions then centrifuged at low speed (5 g) for five minutes. The supernatant fluid
was discarded and 1 ml of fresh MEM, containing appropriate dilutions of various
materials (that is, LP, endotoxin, or protein synthesis inhibitors), was added to
duplicate tubes. The suspensions were then reincubated in the shaking water bath for
an additional 60 minutes. Supernatants from these incubations were obtained by
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low-speed centrifugation and immediately frozen in dry ice and stored at -700C until
assayed. Supernatants from each tube were assayed in duplicate for PGE2 with a
radioimmunoassay kit containing a specific antibody for PGE2 (Seragen, Boston,
MA), thus yielding four data points for each experimental incubation condition. The
means of the duplicate PGE2 assay results were used to calculate the mean for each
duplicate incubation. Results are expressed as pg of PGE2/mg of tissue ± SEM. The
data analysis utilized the paired student's t-test.
Reagents
Cycloheximide was purchased from Boehringer-Mannheim and dissolved in MEM
at a stock solution of 500,ug/ml and kept at -700C. This was diluted in MEM to final
concentrations and added to brain minces. Puromycin was obtained from Sigma and
dissolved in MEM as described above for Cyhx. Polymyxin B was purchased from
Pfizer, dissolved in pyrogen-free water, and stored at 1 mg/ml at 40C. Endotoxin (E.
coli RE-2) was obtained from the Bureau ofBiologics (Bethesda, MD). For endotoxin
levels, the limulus amebocyte lysate test was used (Associates of Cape Cod, Woods
Hole, MA).
RESULTS
The Effect ofPolymyxin B on Hypothalamic PGE2 Production Induced by
Endotoxin or LP
Endotoxin induces the release of LP both in vitro and in vivo. In additon, there are
several experiments which suggest that endotoxin can also actdirectly on the brain and
induce fever; recently endotoxin has been shown to stimulate brain cells to synthesize
PGE2 in vitro [5]. Since endotoxins are seemingly ubiquitous contaminants of many
laboratory reagents, it was not surprising to detect significant levels ofendotoxin in the
MEM used in these studies. Endotoxin levels from 0.1-1 ng/ml were measured in six
different lots ofMEM. Polymyxin B, a positively charged antibiotic, has been shown to
block or inhibit many of the multiple biological activities ofendotoxins, including the
induction of LP in vitro and in vivo [12,13]. Sections of hypothalami were incubated
with either MEM alone, MEM containing 15 ,ug/ml of PmxB, MEM to which
endotoxin had been added (30 pg/ml), or MEM containing both endotoxin and PmxB.
As shown in Fig. 1, background levels ofPGE2 were elevated in control incubations of
hypothalamic tissue in MEM. However, PmxB added to the MEM resulted in
significantly lower levels of PGE2. As an additional test, known amounts ofendotoxin
wereadded to MEM both in theabsenceand thepresenceofPmxB. As shown in Fig. 1,
PmxB inhibits this endotoxin-induced release ofPGE2 from rabbit brain tissue.
The next experiments involved the dose-response effects of human LP in inducing
PGE2 from rabbit hypothalami in the presence ofthese same concentrations of PmxB.
As shown in Fig. 2, PmxB had no effect on LP-induced PGE2 production. In these
experiments, four different lots ofhuman LP purified by the same methods were used.
In each case the activity of the LP in producing fever in the rabbit following
intravenous injections was compared to the induction ofPGE2 in vitro. As shown, I0O
RPD induced significant PGE2 production (p < 0.05).
Effects ofProtein Synthesis Inhibitors on Release ofPGE2
Anterior hypothalamic tissue was incubated with LP and cycloheximide (0.2
,ug/ml). Following the preincubation, both LPand Cyhx wereadded within one minute
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FIG. 1. Effects of various agents on
the release of PGE2 from rabbit ante-
rior hypothalamic tissue. First bar (an-
terior hypothalamus, AH) is control
value for MEM only. Polymyxin (10
units/ml-second bar) was present
during preincubation and standard
incubation at 15 gg/ml. Endotoxin (30
pg/ml) was added to stimulate PGE2
release (third bar). AH was incubated
with both endotoxin and PmxB (fourth
bar). Results are ±SEM and numbers
in parentheses represent the number of
supernatants tested.
ofeach other at room temperature. These incubations were then returned to the water
bath for 60 minutes as described in Methods. The results as depicted in Fig. 3 show
that Cyhx does not inhibit thebackground release ofPGE2 from brain tissue (p > 0.2).
On the other hand, Cyhx significantly reduces the release ofPGE2 from hypothalamic
tissue incubated with purified human LP (p < 0.001). The ability of Cyhx to reduce
LP-induced PGE2production wasconsistently observed in allexperimentsusingall lots
of LP.
In order to further clarify whether Cyhx was having a toxic effect on the brain cells
or interfering with cell metabolism, an additional series ofexperiments was carried out
in which the effect ofCyhx on PGE2 production during the preincubation was studied.
Cyhx was added to brain tissue either both during and after the preincubation step or
only after the preincubation. Regardless of when Cyhx was added to the tissue,
background levels ofPGE2 were not significantly reduced (Fig. 4,p > 0.1). Moreover,
p<0.o00
Iesp<O.002
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FIG. 2. Effects of PmxB on the LP-induced
releaseofPGE2. PmxB (10 units/ml) does not block
LP-induced release of PGE2 from rabbit hypothal-
amic tissue. Concentrations of LP (represented by
numbers underneath the bars) are in rabbit pyro-
genic doses (see text, Methods). Statistical differ-
ences are between experimentals and controls.
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FIG. 3. Cycloheximide effects on the LP-induced
releaseofPGE2. Cycloheximide (Cyhx, 0.2Mg/ml) does
not reduce background release of PGE2 from rabbit
AH (OA2H+CI) 10P Lt-I hypothalamic tissue (first bar versus second bar) but
AH does reduce the amount of PGE2 released by tissue
p>o.2 p<0.00I incubated with LP (third bar versus fourth bar).
Cyhx reduced LP-induced release of PGE2 by similar amounts regardless of whether
the protein synthesis inhibitor was added at the same time as the LP or was present
before and after the addition of LP (Fig. 5).
Cycloheximide has been described as toxic in that when given systemically it can
interfere with the ability of rats and rabbits to maintain normal body temperature
[14,9,15]. Although our experimental design does not reflect possible peripheral
effects ofCyhx, we used another inhibitor ofprotein synthesis, puromycin. Incubation
of hypothalamic tissue with this drug (2 or 10 ,ug/ml) did not significantly affect the
background release ofPGE2 (p> 0.2, Fig. 6). These concentrations ofpuromycin, like
Cyhx, are consistent with the concentrations used in several cell culture systems to
block protein synthesis in a non-toxic, reversible system [16]. Similar to the results
200
Cycloheximide Cycloheximide
present during present only after
ond after preincubotion.
preincubotion. (0.2pLg/mr )
s ~~~(0.2FLg/rnl) p,> 0, I
QL I 00 _ T 4) FIG. 4. The effect of Cyhx added to
IN T(4) hypothalamic cultures without LP. Cyhx
(0.2 Ag/ml) was added during preincubation
QL and during the standard incubation (first
bar) or only during the standard incubation
(second bar). The amount of PGE2 from
rabbit hypothalamic tissue was measured
AH AH following the standard incubation period.
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AH LP Cyhx Cyhx(0.2/xg/mi) FIG. 5. The effect of Cyhx on LP-induced PGE2
AH LPonly Cyho Cyho (O.2/1g/mI)
10-2 (0.2,ug/ml) (preincubotion) production. Cyhx was added either with LP or
+AH +LP C during both the preincubation and standard incu- +AH Cyhx+LP
+AH bation with LP.
obtained using Cyhx, however, the additon ofpuromycin to brain tissue incubated with
LP resulted in a 50 percent reduction in the amount of PGE2 detected in the
supernatant after 60 minutes (Fig. 6).
DISCUSSION
The initial results of these studies indicate that commercial media such as MEM
probably contain sufficient levels ofendotoxin to affect our experimental conditions by
stimulating brain PGE2 production in vitro. The addition ofpolymyxin B to the media
eliminates or significantly reduces the ability of such contaminating endotoxins to
induce PGE2 release or production from rabbit hypothalamic tissue. The antibiotic,
however, does not affect the ability of LP to induce the synthesis ofPGE2 from rabbit
hypothalamic tissue, and these results are consistent with previous studies demonstrat-
ing that LP and endotoxin effects on in vitro PGE2 production are separable [5]. Not
all lots ofMEM contain the same amounts ofendotoxin, and thus background levels of
PGE2 induced by media alone may vary from experiment to experiment. This problem
was overcome by including polymyxin B in the culture media of all subsequent
incubations and provided the opportunity to carry out these studies without endotoxin
contamination as a contributing factor. As shown by other investigators [12,13], the
addition ofthis antibiotic to culture media is especially important when various agents
are employed in pyrogen experiments for their ability to stimulate the production and
release ofLP. We can now add that production ofPGE2 from brain, whether in vitroor
in vivo, can also be affected by contaminating endotoxins and that the inclusion of
polymyxin B can block potential endotoxin effects.
Once we were able to obtain consistent results using PmxB in the hypothalamic
incubations, studies were carried out in order to investigate the effect ofthe antipyretic
protein synthesis inhibitors on brain PGE2 production in vitro. Cycloheximide, a potent
inhibitor of protein synthesis in vitro, has been used as a chemotherapeutic agent in
certain cancers, and patients receiving the drug during a febrile illness undergo a
dramatic reduction in fever within an hour following an infusion of the drug [6]. In
addition, administration of Cyhx to animals receiving either endotoxin or LP
eliminates or lowers their fevers [7,8,9]. Investigations have shown that this antipyresis
is not due to Cyhx preventing pyrogens from entering the brain from the circulation
since fevers produced by LP or endotoxin given intracerebroventricularly (ICV) can
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i °° 9 0 S FIG. 6. Effect ofpuromycin on the release
of PGE2 from hypothalamic tissue. Puromy-
AH 2jig I0jjg LP* 2Pg OA cin was added to hypothalamic tissue alone
puromycin 10-2 puromycin + or in the presence of LP. Concentrations of
+AH +AH LP AAH puromycin are shown in micrograms/ml.
still be inhibited by Cyhx [17,3]. Moreover, the doses ofCyhx which are antipyretic in
rabbits given exogenous pyrogens are not sufficient to prevent the synthesis of LP in
vivo [8]; however, this is in contrast tothefact thatboth Cyhxand puromycin block LP
synthesis when added to phagocytes at the time of stimulation with exogenous
pyrogens in vitro [16,18].
The mechanism for protein synthesis inhibitors acting as antipyretics remains
unclear. Siegert et al. [8] have shown that Cyhx reduces fever without affecting
cerebrospinal fluid levels ofPGE2. However, recent results have shown that Cyhx does
not interfere with the production of fever caused by the administration of PGE2 or
arachidonic acid [17,19]. In addition, Cyhx inhibits the in vitro release ofprostaglan-
dins from mouse BALB/3T3 cells treated with methylcholanthrene [20], whilevarious
other protein synthesis inhibitors reduce the LP-induced release ofPGE2 from human
dermal fibroblasts [21,22]. These later findings as well as those reported in this paper
indicate that protein synthesis inhibitors may exert their antipyretic effect by
interfering with the synthesis ofPGE2.
In the present studies, we consistently observed that hypothalamic tissue incubated
with Cyhx and LP released significantly less amounts of PGE2 than tissue incubated
with LP alone. In addition, background levels of PGE2 released by these tissues were
unaffected by the presence of Cyhx. Similar results were obtained when another
protein inhibitor, puromycin, was used. These data do not rule out the possibility that
protein synthesis inhibitors are toxic to brain tissue and thereby decrease its ability to
respond to LP; on the other hand, recent evidence shows that protein synthesis
inhibitors are non-toxic to human dermal fibroblasts [21]. In these experiments, the
ability offibroblasts to release PGE2 in response to LP was decreased by the presence
of Cyhx; however, fibroblasts incubated for various time periods with Cyhx retained
their viability and showed no decrease in background PGE2 production. These results
support the concept that inhibitors of protein synthesis block some synthetic step
leading to LP-induced release of PGE2 rather than simply injuring or killing the
responding cells.
The synthetic step blocked by protein synthesis inhibitors is unknown. However,
since fibroblasts synthesize PGE2 in the presence ofboth arachidonic acid and protein
synthesis inhibitors it is unlikely that inhibitors of protein synthesis interfere signifi-
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cantly with the activity ofcyclo-oxygenase (preliminary data and [211). On the other
hand, it may be that LP induces PGE2 release by first activating a phosphodiesterase
enzyme which cleaves diacylglycerol (DAG) from phosphotidylinositol [231. The
DAG so formed may have arachidonic acid on its 2-position, which in turn could be
cleaved by a specific enzyme (a diacylglycerol lipase and/or a phosphatidic acid
specific phospholipase-23). Protein synthesis inhibitors may therefore decrease the
LP-induced release of PGE2 by interfering with the synthesis of one or more of the
enzymes involved in the release ofarachidonic acid.
Another protein synthesis inhibitor, anisomycin, which is less toxic than Cyhx in
that it does not interfere with normal thermoregulation ofrats or rabbits [24], blocks
or significantly reduces fever induced by either endotoxin or LP [25,26]. Unlike Cyhx,
however, anisomycin also prevents fevers induced by PGE2 [27]. In addition, after
administration of endotoxin, anisomycin treatment results in an increased amount of
PGE2 in the cerebrospinal fluid [3]. It is unclear whether the same results would be
obtained iffever were induced by an injection ofLP instead oflarge intravenous doses
ofendotoxin which probably induce PGE2 production from cells throughout the brain
[5]. Recent results from this laboratory [22] and elsewhere [21] indicate that
anisomycin inhibits the LP-induced release of PGE2 from fibroblasts and may,
therefore, alsodecreasethe LP-induced releaseofPGE2 from hypothalamictissue. It is
also possible that inhibitors of protein synthesis which are also antipyretics may not
induce antipyresis by the same mechanism.
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